Skip to main content
Equibles
CREX logo

CREX · Creative Realities, Inc. · Metrics

Track CREX — free

Use CREX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CREX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.18 -0.05 (-2.24%) At close · Oct 23
Rebalance outlook locked
Going-concern doubt — cleared Aug 14, 2026

The latest filing states the doubt was alleviated.

“These actions have alleviated the substantial doubt about the Company's ability to continue as a going concern that previously existed, and accordingly, there no longer exists substantial doubt about the Company's ability to continue as a going concern for at least twelve months after these condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$29.49M
Shares
13.53M
Volume · Oct 23 10.27K Avg daily vol (3M) 31.1K

CREX metrics

82 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.18
Market cap
$29.49M

Price action

20 metrics
Price change (1W)
+1.4%
Price change (30D)
-11.2%
Price change (3M)
-31.9%
Price change (6M)
-43.1%
Price change (YTD)
-16.5%
Price change (1Y)
-34.1%
Trailing year
Price change (5Y)
—
52-week high
$4.15
52-week low
$2.10
Change from 52-week high
-47.5%
Change from 52-week low
+3.8%
Annualized volatility
55.8%
Annualized volatility (3M)
52.9%
Beta
1.2
RSI (14D)
33.9
Price vs SMA 50
-15.9%
Price vs SMA 200
-34.1%
Avg volume (3M)
31,104
Relative volume
0.3
Average dollar volume
$84,521

Company

3 metrics
Sector
Technology
Industry
Software - Application
Shares outstanding
13.53M

Valuation

12 metrics
P / E (TTM)
11.2
Trailing earnings · reciprocal yield 8.9%
PEG ratio
—
EV / revenue
0.9×
reciprocal yield 110.5%
EV / EBITDA
8.5×
reciprocal yield 11.8%
EV / EBIT
—
P / sales
0.4×
reciprocal yield 245.3%
P / book
1.5
reciprocal yield 65.0%
FCF yield
-26.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-71.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.0×
reciprocal yield 97.7%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 95.7%
EV / EBIT historical average (3Y)
47.7×
reciprocal yield 2.1%
EV / EBIT historical average (5Y)
47.7×
reciprocal yield 2.1%
EV / EBITDA historical average (3Y)
32.6×
reciprocal yield 3.1%
EV / EBITDA historical average (5Y)
32.6×
reciprocal yield 3.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
41.7%
Operating margin
-21.8%
Trailing 12 months
Net margin
-29.3%
Gross profit (TTM)
$30.14M
Operating profit (TTM)
−$15.76M
Net income (TTM)
−$21.18M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-10.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.04

Growth

11 metrics
Revenue growth YoY
+65.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$72.32M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
+9.7%
Revenue CAGR (5Y)
+26.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-110.6%
Return on assets
-14.8%
Debt / equity
2.4
Current ratio
0.9
EBITDA (TTM)
$4.64M
Free cash flow (TTM)
−$7.72M
Quick ratio
0.7
Interest coverage
-3.5
Net debt / EBITDA
2.1
Return on invested capital
—
Trailing 12 months
Net cash
−$35.94M
Latest balance sheet
Cash & equivalents
$10.70M
Total assets
$142.94M
Total debt
$46.64M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$5.07M
Capital expenditures (TTM)
$2.65M
R&D (TTM)
$1.72M
SG&A (TTM)
—
Stock compensation (TTM)
$1.65M
R&D / revenue
—
Stock compensation / revenue
2.3%

Ownership (13F)

9 metrics
13F filers
36
13F filer change QoQ
+6
Institutional ownership
28.1%
Conviction holders (share of 13F filers)
2.8%
Crowding (high-turnover and private-fund holders)
23.4%
Private-fund adviser ownership
23.4%
Active holders' share change QoQ
+66.5%
Holder tenure
4.4
Price vs estimated holder cost
+20.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.7%

Short interest

3 metrics
Short interest
0.2%
Latest settlement · 1.2 days to cover
Days to cover
1.2d
Short-squeeze score
26 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1356093 CUSIP 22530J309 13F (30d) 1 filings 1 filers Visit website Investor relations